1. Home
  2. WGRX vs MDAI Comparison

WGRX vs MDAI Comparison

Compare WGRX & MDAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • WGRX
  • MDAI
  • Stock Information
  • Founded
  • WGRX 2022
  • MDAI 2013
  • Country
  • WGRX United States
  • MDAI United States
  • Employees
  • WGRX N/A
  • MDAI N/A
  • Industry
  • WGRX Other Pharmaceuticals
  • MDAI Medical/Dental Instruments
  • Sector
  • WGRX Health Care
  • MDAI Health Care
  • Exchange
  • WGRX Nasdaq
  • MDAI Nasdaq
  • Market Cap
  • WGRX 63.6M
  • MDAI 69.0M
  • IPO Year
  • WGRX 2025
  • MDAI N/A
  • Fundamental
  • Price
  • WGRX $0.82
  • MDAI $2.04
  • Analyst Decision
  • WGRX
  • MDAI Strong Buy
  • Analyst Count
  • WGRX 0
  • MDAI 1
  • Target Price
  • WGRX N/A
  • MDAI $3.50
  • AVG Volume (30 Days)
  • WGRX 5.2M
  • MDAI 408.8K
  • Earning Date
  • WGRX 08-26-2025
  • MDAI 08-12-2025
  • Dividend Yield
  • WGRX N/A
  • MDAI N/A
  • EPS Growth
  • WGRX N/A
  • MDAI N/A
  • EPS
  • WGRX N/A
  • MDAI N/A
  • Revenue
  • WGRX $36,907,109.00
  • MDAI $27,549,000.00
  • Revenue This Year
  • WGRX N/A
  • MDAI N/A
  • Revenue Next Year
  • WGRX N/A
  • MDAI $15.15
  • P/E Ratio
  • WGRX N/A
  • MDAI N/A
  • Revenue Growth
  • WGRX N/A
  • MDAI 22.27
  • 52 Week Low
  • WGRX $0.62
  • MDAI $0.82
  • 52 Week High
  • WGRX $7.04
  • MDAI $3.25
  • Technical
  • Relative Strength Index (RSI)
  • WGRX N/A
  • MDAI 35.56
  • Support Level
  • WGRX N/A
  • MDAI $1.98
  • Resistance Level
  • WGRX N/A
  • MDAI $2.24
  • Average True Range (ATR)
  • WGRX 0.00
  • MDAI 0.16
  • MACD
  • WGRX 0.00
  • MDAI -0.04
  • Stochastic Oscillator
  • WGRX 0.00
  • MDAI 10.53

About WGRX Wellgistics Health Inc. Common Stock

Wellgistics Health Inc is a healthcare technology and pharmaceutical logistics company. It simplifies the logistics of prescription fulfillment from the manufacturer and provider to the patient. It is focused on improving the lives of patients while delivering unique solutions for pharmacies, providers, pharmaceutical manufacturers, and payors.

About MDAI Spectral AI Inc.

Spectral AI Inc is an AI company, focused on predictive medical diagnostics. Spectral is devoting substantially all of its efforts towards the research and development of its DeepView System, an internally developed MSI device that has designated FDA BDD status. Its DeepView System uses proprietary algorithms to distinguish between damaged and healthy human tissue invisible to the naked eye, providing Day One healing assessments in seconds. The Company's output is specifically engineered to allow the physician to make a more accurate, timely, and informed decision regarding the treatment of the patient's wound.

Share on Social Networks: